SCHEMBL764568

SCHEMBL764568

COCCOC(=O)Nc1ccc(N)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 8/20 0.53
ALDH1A1 P00352 2/20 0.53
MAPK1 P28482 2/20 0.53
RAB9A P51151 8/20 0.50
NPC1 O15118 7/20 0.50
HPGD P15428 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
CASP1 P29466 1/20 0.50
LMNA P02545 2/20 0.49
TP53 P04637 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
TDP1 Q9NUW8 2/20 0.49
MEN1 O00255 1/20 0.49
POLB P06746 1/20 0.49
PKM P14618 1/20 0.49
APEX1 P27695 1/20 0.49
KMT2A Q03164 1/20 0.49
MAPT P10636 3/20 0.48
KDM4E B2RXH2 2/20 0.47
TSHR P16473 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8238907 0.85 PKM (0.58) SMN1; SMN2ALDH1A1MAPK1RAB9ANPC1
SCHEMBL2070195 0.85 SMN1; SMN2 (0.71) SMN1; SMN2ALDH1A1MAPK1RAB9ANPC1
SCHEMBL22700779 0.83 RAB9A (0.50) SMN1; SMN2ALDH1A1MAPK1RAB9ANPC1
SCHEMBL5623097 0.83 NPC1 (0.68) SMN1; SMN2ALDH1A1RAB9ANPC1HPGD
SCHEMBL3007602 0.82 CSNK2A2 (0.60) SMN1; SMN2ALDH1A1MAPK1RAB9ANPC1
SCHEMBL13073361 0.82 RAB9A (0.56) SMN1; SMN2ALDH1A1MAPK1RAB9ANPC1
SCHEMBL27701440 0.82 RAB9A (0.73) SMN1; SMN2ALDH1A1MAPK1RAB9ANPC1
SCHEMBL854996 0.81 RAB9A (0.61) SMN1; SMN2ALDH1A1MAPK1RAB9ANPC1
SCHEMBL842249 0.81 NPC1 (0.48) SMN1; SMN2ALDH1A1MAPK1RAB9ANPC1
SCHEMBL3009762 0.81 BCHE (0.68) SMN1; SMN2ALDH1A1MAPK1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2431369-A2 Carboline derivatives useful in the inhibition of angiogenesis PTC Therapeutics, Inc. (US) 2012-03-21 EP disclosed